NCT06974734 2026-04-23A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic MalignanciesPfizerPhase 1 Terminated8 enrolled
NCT05293496 2025-10-14A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid TumorsMacroGenicsPhase 1 Completed31 enrolled